IronBridge Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$3.76M Buy
189,639
+28,119
+17% +$628K 0.23% 135
2016
Q4
$3.89M Sell
161,520
-585
-0.4% -$16.3K 0.17% 128
2016
Q3
$4.5M Sell
162,105
-17,426
-10% -$461K 0.21% 122
2016
Q2
$4.38M Buy
179,531
+41,581
+30% +$1.18M 0.19% 124
2016
Q1
$4.63M Buy
137,950
+1,029
+0.8% +$32.4K 0.19% 131
2015
Q4
$4.09M Buy
136,921
+48,684
+55% +$1.64M 0.16% 129
2015
Q3
$2.78M Buy
88,237
+15,145
+21% +$739K 0.11% 145
2015
Q2
$3.54M Buy
+73,092
New +$3.08M 0.11% 144

Other funds holding PGEN

IronBridge Capital Management's PGEN Position: Q1 2017 in Review

IronBridge Capital Management increased its Precigen (PGEN) stake by 17% in Q1 2017, buying an estimated $628K and bringing the position to 189,639 shares worth $3.76M. The position accounts for 0.23% of the portfolio, ranked #135.

IronBridge Capital Management first reported a position in PGEN in Q2 2015 and has held it in 8 quarters since. The position peaked at $4.63M in Q1 2016. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

  • IronBridge Capital Management held 189,639 shares of Precigen worth $3.76M as of Q1 2017.
  • IronBridge Capital Management bought 28,119 Precigen shares in Q1 2017, an estimated $628K.
  • Precigen made up 0.23% of IronBridge Capital Management's portfolio in Q1 2017, its #135 holding.
  • IronBridge Capital Management first reported a position in Precigen in Q2 2015 and has held it in 8 quarters since.
  • IronBridge Capital Management's Precigen position peaked at $4.63M in Q1 2016.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.